Cholesterol test launch
This article was originally published in The Tan Sheet
Executive Summary
Predictive medicine technology developer International Medical Innovations (IMI) will introduce its PREVU Point of Care cholesterol test for the physician, clinic and pharmacist in the first quarter of 2005. The UK switch of statin Zocor to nonprescription status "shows that point-of-care counseling by healthcare professionals is a key focus in combating heart disease," IMI says. "We expect this environment to create important opportunities for PREVU Skin Sterol Test as a new tool for risk assessment." McNeil Consumer Healthcare markets the product worldwide (1"The Tan Sheet" June 7, 2004, p. 10). The consumer version of PREVU will enter clinical trials in the first half of 2005...